Biotech Startups

Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.

1 investor

Forever Harvest is a cellular horticulture company that grows fruit and nut cells in controlled environments, developing plant cell lines and growth media to produce custom fruit and nut ingredients for industry partners. It offers on-demand ingredient supply with tailored functional and flavour profiles, produced without genetic modification.

1 investor

Forge Therapeutics operates a drug discovery platform focused on developing medicines that target human metalloenzymes. The company works on a pipeline of therapeutic programs based on this metalloenzyme-targeting approach.

1 investor

Fortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.

1 investor

Forward Therapeutics develops oral small-molecule medicines targeting inflammation-driven diseases, using a structure-based, data-driven discovery engine to design drugs against validated pathways. The company applies expertise in chemistry, immunology, CNS biology, and clinical development.

1 investor

ForwardVue Pharma develops a long-acting ORAI1 blocker administered by intravitreal injection to treat retinal neovascular disease, with a target dosing of 1-2 injections per year for durability up to 12 months. The company operates in ophthalmic drug development.

1 investor

Foundational Bio is building an AI-native, fully automated laboratory ("self-driving lab") that replaces manual workflows to increase the speed and reliability of life-science experimentation. It serves the life sciences and research sector.

1 investor

The Founder-Led Biotech Tour is an event series and networking initiative that connects biotech founders, scientists, investors, and ecosystem partners through in-person and virtual events such as speed networking and co-founder matching. It grew out of the Founder-Led Biotech Summit and supports a new generation of biotech company founders.

1 investor

Foundry BioSciences develops protein language models powered by AI for protein engineering to address aging and longevity. The company serves users, partners, and patients globally through novel protein sequences.

1 investor

Fourien develops microfluidics-based instruments and sensors for nanoscale diagnostics and analytical measurements in biotech and pharmaceutical industries. The company uses advanced nanofabrication and electronics assembly to create low-cost, rapid testing solutions.

1 investor

Fred Hutch is a cancer research institute that develops biomarkers, therapies, and stem cell products for research and clinical use, and provides data infrastructure and funding to commercialize discoveries into treatments and spinout companies.

1 investor

Frekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.

1 investor

1 investor

Frontage is a contract research organization offering drug candidate evaluation services including screening, DMPK, drug safety assessment, and bioanalysis, along with formulation development and CMC services from discovery through post-approval. It also runs clinical research and a central laboratory providing lab testing, global logistics, and project management for pharmaceutical clients.

1 investor

Frontera Therapeutics is a biotechnology company engaged in therapeutic research and development, spanning translational medicine, clinical operations, and manufacturing.

1 investor

Frontier Space Technologies develops in-space R&D and biomanufacturing platforms that use the microgravity space environment to accelerate biotechnology work. The UK-based company aims to make the space environment more accessible for biotech applications benefiting life on Earth.

1 investor

VisualSonics develops ultra-high frequency ultrasound and photoacoustic imaging systems for preclinical research, enabling real-time visualization of anatomical, functional, and molecular data in small animals. The company serves biomedical researchers requiring non-invasive in vivo imaging for drug development and life sciences research.

1 investor

1 investor

1 investor

Fulmz offers an AI-powered platform for drug discovery that combines molecular design, large-scale screening, and computational optimization to accelerate the development of small molecule drugs. The platform serves pharmaceutical researchers and drug development organizations seeking to compress preclinical research timelines.

1 investor

FUNBRUSH develops an antifouling and antibacterial nanocoating for biosensors and bioanalytical platforms, enabling sensitive detection in complex, undiluted sample media such as blood plasma, food, and environmental samples. It targets applications in diagnostics, healthcare, food safety, security, and environmental monitoring, and is compatible with SPR, QCM, optical fiber, and electrochemical sensor platforms.

1 investor

FunCell develops BioGraft, a technology that adds functional properties like barrier capabilities to paper and cellulosic materials, enabling new applications in the packaging industry. The company provides chemistry expertise and industrial research services to innovate cellulose-based packaging solutions.

1 investor

Mission Bay Capital is an early-stage investment firm dedicated to funding and supporting entrepreneur-scientists building companies to address chronic diseases and environmental challenges. The firm provides capital, laboratory facilities through its incubator MBC BioLabs, and access to a network of advisors and industry partners.

1 investor

Fundació Villavecchia is a foundation that supports research, specialized training for medical professionals, and hospital improvements in the fight against childhood cancer. The organization funds research registries, awards fellowships and scholarships for pediatric oncology and hematology specialists, and collaborates with hospital centers to improve patient and family experiences.

1 investor